ADMA Biologics ADMA Total Cost of Revenue
Total Cost of Revenue at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:CostOfRevenue.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ADMA Biologics's total cost of revenue?
- ADMA Biologics (ADMA) reported total cost of revenue of $33.74M in Q1 2026.
- How has ADMA Biologics's total cost of revenue changed year-over-year?
- ADMA Biologics's total cost of revenue decreased by 37.2% year-over-year, from $53.71M to $33.74M.
- What is the long-term trend for ADMA Biologics's total cost of revenue?
- Over 4 years (2021 to 2025), ADMA Biologics's total cost of revenue has grown at a 28.5% compound annual growth rate (CAGR), from $79.77M to $217.41M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.